Sign in

CIK 0001875558

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Nuvectis Pharma, Inc.

Sign in to watch
Ticker
NVCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
862405608
Phone
+1 360-837-7232
Business address
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Hoberman Kenneth Director Grant or award +35,000 168,140
2025-06-12 Hoberman Kenneth Director Grant or award +30,000 133,140
2024-06-13 Hoberman Kenneth Director Grant or award +30,000 103,140
2023-06-16 Hoberman Kenneth Director Grant or award +18,000 73,140
2022-05-12 Hoberman Kenneth Director Purchase +6,000 $17.40 $104K 55,140
2022-04-01 Hoberman Kenneth Director Grant or award · Stock Options (right to buy) +15,000 15,000

Page 1 of 1 · 6 trades